ATC代码 (A10) - 维基百科,自由的百科全书
ATC代码 |
---|
A 消化系统和代谢系统 |
A01 口腔病药物 (Stomatological preparations) |
A02 治疗与胃酸分泌相关疾病的药物 (Drugs for acid related disorders) |
A03 肠胃机能失调用药 (Drugs for functional gastrointestinal disorders) |
A04 止吐药及止恶心药 (Antiemetics and antinauseants) |
A05 肝、胆疾病治疗药 (Bile and liver therapy) |
A06 轻泻药 (Laxatives) |
A07 止泻药、肠道消炎药、肠道抗感染药 (Antidiarrheals, intestinal anti-inflammatory /anti-infective agents) |
A08 减肥制剂,不包含饮食制品 (Antiobesity preparations, excluding diet products) |
A09 消化药,包括酶 (Digestives, including enzymes) |
A10 糖尿病用药 (Drugs used in diabetes) |
A11 维生素 (Vitamins) |
A12 矿物补充剂 (Mineral supplements) |
A13 补药 (Tonic) |
A14 同化作用药 (Anabolic agents for systemic use) |
A15 食欲促进剂 (Appetite stimulants) |
A16 其它消化道及新陈代谢用药 (Other alimentary tract and metabolism products) |
|
ATC代码A10(糖尿病用药)是解剖学治疗学及化学分类系统的一个药物分组,这是由世界卫生组织药物统计方法整合中心(The WHO Collaborating Centre for Drug Statistics Methodology)所制定的药品及其它医用产品的官方分类系统。分组A10是A消化系统和代谢系统的一部分。[1]
兽用代码(ATCvet码)可以在人用ATC代码前加Q字母:QA10等[2]。
国家ATC分类可能包括列表中没有的其它分类,列表为世界卫生组织(WHO)版本。
A10A 胰岛素及其同系物(Insulins and analogues)
[编辑]- A10AB01 人胰岛素(Insulin (human))
- A10AB02 牛胰岛素(Insulin (beef))
- A10AB03 猪胰岛素(Insulin (pork))
- A10AB04 赖脯胰岛素(Insulin lispro)
- A10AB05 门冬胰岛素(Insulin aspart)
- A10AB06 赖谷胰岛素(Insulin glulisine)
- A10AB30 复方(Combinations)
A10AC 注射用胰岛素及其类似药物,中效(Insulins and analogues for injection, intermediate-acting)
[编辑]- A10AC01 人胰岛素(Insulin (human))
- A10AC02 牛胰岛素(Insulin (beef))
- A10AC03 猪胰岛素(Insulin (pork))
- A10AC04 赖脯胰岛素(Insulin lispro)
- A10AC30 复方(Combinations)
A10AD 注射用胰岛素及其同系物,中效与快效结合的(Insulins and analogues for injection, intermediate-acting combined with fast-acting)
[编辑]- A10AD01 人胰岛素(Insulin (human))
- A10AD02 牛胰岛素(Insulin (beef))
- A10AD03 猪胰岛素(Insulin (pork))
- A10AD04 赖脯胰岛素(Insulin lispro)
- A10AD05 门冬胰岛素(Insulin aspart)
- A10AD30 复方(Combinations)
A10AE 注射用胰岛素及其类似药物,长效(Insulins and analogues for injection, long-acting)
[编辑]- A10AE01 人胰岛素(Insulin (human))
- A10AE02 牛胰岛素(Insulin (beef))
- A10AE03 猪胰岛素(Insulin (pork))
- A10AE04 甘精胰岛素(Insulin glargine)
- A10AE05 地特胰岛素(Insulin detemir)
- A10AE30 复方(Combinations)
A10AF 注射用胰岛素及其类似药物(Insulins and analogues for inhalation)
[编辑]- A10AF01 人胰岛素(Insulin (human))
- A10BB01 格列本脲(Glibenclamide)
- A10BB02 氯磺丙脲(Chlorpropamide)
- A10BB03 甲磺丁脲(Tolbutamide)
- A10BB04 格列波脲(Glibornuride)
- A10BB05 妥拉磺脲(Tolazamide)
- A10BB06 氨磺丁脲(Carbutamide)
- A10BB07 格列吡嗪(Glipizide)
- A10BB08 格列喹酮(Gliquidone)
- A10BB09 格列齐特(Gliclazide)
- A10BB10 美他己脲(Metahexamide)
- A10BB11 格列派特(Glisoxepide)
- A10BB12 格列美脲(Glimepiride)
- A10BB31 醋酸己脲(Acetohexamide)
A10BC 磺胺类,杂环(Sulfonamides (heterocyclic))
[编辑]- A10BC01 格列嘧啶(Glymidine)
A10BD 口服降糖药复方(Combinations of oral blood glucose lowering drugs)
[编辑]- A10BD01 苯乙双胍和磺胺类(Phenformin and sulfonamides)
- A10BD02 二甲双胍和磺胺类(Metformin and sulfonamides)
- A10BD03 二甲双胍和罗格列酮(Metformin and rosiglitazone)
- A10BD04 格列美脲和罗格列酮(Glimepiride and rosiglitazone)
- A10BD05 二甲双胍和吡格列酮(Metformin and pioglitazone)
- A10BD06 格列美脲和吡格列酮(Glimepiride and pioglitazone)
- A10BD07 二甲双胍和西格列汀(Metformin and sitagliptin)
- A10BD08 二甲双胍和维格列汀(Metformin and vildagliptin)
- A10BD09 吡格列酮和阿格列汀(Pioglitazone and alogliptin)
- A10BD10 二甲双胍和沙格列汀(Metformin and saxagliptin)
- A10BD11 二甲双胍和利拉利汀(Metformin and linagliptin)
A10BH 二肽基肽酶4(DPP-4)抑制剂(Dipeptidyl peptidase 4 (DPP-4) inhibitors)
[编辑]- A10BH01 西格列汀(Sitagliptin)
- A10BH02 维格列汀(Vildagliptin)
- A10BH03 沙格列汀(Saxagliptin)
- A10BH04 阿格列汀(Alogliptin)
- A10BH05 利拉利汀(Linagliptin)
- A10BJ01 艾塞那肽 exenatide
- A10BJ02 利拉鲁肽 liraglutide
- A10BJ03 lixisenatide
- A10BJ04 albiglutide
- A10BJ05 dulaglutide
- A10BJ06 semaglutide
A10BK 鈉-葡萄糖共同轉運蛋白2(Sodium-glucose co-transporter 2 (SGLT2) inhibitors)
[编辑]- A10BX01 瓜耳树胶(Guar gum)
- A10BX02 瑞格列奈(Repaglinide)
- A10BX03 那格列奈(Nateglinide)
- A10BX05 普兰林肽(Pramlintide)
- A10BX06 苯氟雷司(Benfluorex)
- A10BX08 米格列奈(Mitiglinide)
- A10XA01 托瑞司他(Tolrestat)
参考文献
[编辑]- ^ ATC Index. WHO Collaborating Centre for Drug Statistics Methodology.
- ^ ATCvet Index. WHO Collaborating Centre for Drug Statistics Methodology.